References
- Ferrari S, Zolezzi C, Cesari M, Fasano MC, Lamanna G, Bacci G. Prospective evaluation of high-dose ifosfamide-relat-ed nephrotoxicity in young adult patients with recurrent osteosarcoma previously treated with cisplatin, methotrexate and standard-dose ifosfamide. Anticancer Drugs 1999; 10 (1): 25–31.
- Skinner R, Pearson AD, Price L, Cunningham K, Craft AW. Hypophosphatamic rickets after ifosfamide treatment in children. Br Med J 1989; 298: 1560–1561.
- Skinner R, Sharkey IA, Pearson ADJ, Craft AW. Ifosfamide, mesna and nephrotoxicity in children. J Clin Oncol 1993; 11: 173–190.
- Skinner R, Pearson AD, Price L, Coulthard MG, Craft AW. The influence of age on nephrotoxicity following chemotherapy in children. Br J Cancer 1992; 18: S–30–35.
- Pratt CB, Meyer WH, Jenkins JJ, et al. Ifosfamide, Fanconi's syndrome, and rickets. J Clin Oncol 1991; 9: 1495–1499.
- Rossi R, Danzebrink S, Hillebrand D, Linnenburger K, Ullrich K, Jurgens H. Ifosfamide induced subclinical nephro-toxicity and its potentiation by cisplatinum. Med Pediatr Oncol 1994; 22 (1): 27–32.
- Campolat C, Pearson P, Robertson R, Jaffe N. Ifosfamide tolerance in osteosarcoma patients previously treat-ed with cis-diamminedichloroplatinum II: renal, hematologic and neurologic observations. Med Pediatr Oncol 1996; 26: 36–47.
- Ho PTC, Zimmerman K, Wexler LH, et al. A prospec-tive evaluation of ifosfamide related nephrotoxicity in children and young adults. Cancer 1995; 76 (12): 2557–2564.
- Randers E, Kristensen JH, Erlandsen EJ, Danielsen H. Serum cystatin C as a marker of the renal function. Scand J Clin Lab Invest 1998; 58: 585–591.
- Swan SK. The search continues an ideal marker of GFR. Clin Chem 1997; 43: 913–914.
- Grubb A. Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clin Nephrol 1992; 38 (51): 20–27.
- Brzin J, Popovic T, Turk V. Human cystatin, a new protein inhibitor of cysteine proteinases. Biochem Biophys Res Commun 1984; 118: 103–106.
- Barrett AJ, Fritz H, Grubb A, et al. Nomenclature and classification of the proteins homologous with the cysteine-proteinase inhibitor chicken cystatin. Biochem J 1986; 236: 312–316.
- Rawlings ND, Barrett AJ. Evolution of proteins of the cystatin superfamily. J Mol Evol 1990; 30: 60–71.
- Barrett AJ, Davies ME, Grubb A. The place of human y-trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochem Biophis Res Commun 1984; 120: 631–636.
- Abrahamson M, Olafsson I, Palsdottir A, et al. Structure and expression of the human cystatin C gene. Biochem J 1990; 268: 287–294.
- Lofberg H, Grubb AO. Quantitation of y-trace in human biological fluids: indications for production in the cen-tral nervous system. Scand J Clin Lab Invest 1979; 39: 619–626.
- Abrahamson M, Barrett AJ, Salvesen G, Grubb A. Isolation of six cysteine proteinase inhibitors from human urine. J Biol Chem 1986; 261: 11282–11289.
- Hall A, Hakansson K, Mason RW, Grubb A, Abrahamson M. Structural basis for the biological specificity of cystatin C. J Biol Chem 1995; 270: 5115–5121.
- Grubb A, Simonsen G, Sturfelt G, Trueddsson L, Thysell H. Serum concentration of cystatin C, factor D and y2-microglobulin as a measure of glomerular filtration rate. Acta Med Scand 1985; 218 : 499–503.
- Tenstad O, Roald AB, Grubb A, Aukland K. Renal han-dling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest 1996; 56: 409–414.
- Nilsson-Ehle P, Grubb A. New markers for the determi-nation of GFR: johexol clearence and cystatin C serum con-centration. Kidney Int 1994; 46 (47): 17–19.
- Kyhse-Ansersen J, Schmidt C, Nordin G, et al. Serum cystatin C, determined by a rapid automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 1994; 40: 1921–1926.
- Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function- a review. Clin Chem Lab Med 1999; 37 (4): 389–395.
- Mussap M, Plebani M. Vecchi e nuovi marcatori biochimici di filtrazione renale: il caso della cistatina C. Biochimica Clinica 1999; 23 (3): 143–160.
- Helin I, Axenram M, Grubb A. Serum cystatin C as a determinant of glomerular filtration rate in children. Clin Nephrol 1998; 49: 221–225.
- Stickle D, Cole B, Hock K, Hruska KA, Scott MG. Correlation of plasma concentrations of cystatin C and creati-nine to insulin clearance in a pediatric population. Clin Chem 1998; 44: 1334–1338.
- Newman DJ, Thakkar H, Edwards RG, et al. Serum cystatin C measured by automated immunoassay: a more sen-sitive marker of changes in GFR than serum creatinine. Kidney Int 1995; 47: 312–318.
- Bokenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J. Cystatin C-a new marker of glomerular filtration rate in children independent of age and high. Pediatrics 1998; 101: 875–881.
- Fanos V, Mussap M, Plebani M, Cataldi L. Cystatin C in pediatric nephrology. Min Pediatr 1999; 51: 1–8.
- Filler G, Witt I, Priem F, Ehrich JHH, Jung K. Are cys-tatin C and 132-microglobulin better markers than serum creati-nine for prediction of a normal glomerular filtration rate in pediatric subjects? Clin Chem 1997; 43: 1077-1078.
- Johnson AM. Low levels of plasma proteins: malnutri-tion or inflammation? Clin Chem Lab Med 1999; 37: 91–96.
- Cochcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16 (1): 31–41.